|
|
||||||||
Ann Thorac Surg 2005;80:170-178
© 2005 The Society of Thoracic Surgeons
a Department of Radiology, Section of Cardiovascular Imaging, Cleveland Clinic Foundation, Cleveland, Ohio
b Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio
c Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic Foundation, Cleveland, Ohio
d Department of Biostatistics and Epidemiology, Cleveland Clinic Foundation, Cleveland, Ohio
Accepted for publication January 10, 2005.
* Address reprint requests to Dr White, Center for Integrated Non-Invasive Cardiovascular Imaging, Desk HB6, Cleveland Clinic Foundation, 9500 Euclid Ave, Cleveland, OH44195 (Email: whiter{at}ccisd1.ccf.org).
BACKGROUND: Mitral regurgitation (MR) is a common complication of ischemic heart disease, and its presence portends adverse outcomes. As the exact mechanisms of ischemic MR are not well defined, we characterized left ventricular global geometry, regional function, and regional myocardial scarring, in addition to mitral valve apparatus geometry, using magnetic resonance imaging (MRI) of ischemic heart disease patients with left ventricular dysfunction and varying degrees of ischemic MR.
METHODS: Sixty patients with varying degrees of MR (none, mild, moderate, and severe) determined by echocardiography and referred for MRI assessment of ischemic heart disease were included. Left ventricular geometric, functional, and scar measurements in addition to mitral valve geometric measurements were evaluated.
RESULTS: Clinical characteristics found to be significant predictors of degree of MR included severity of coronary artery disease (p < 0.05), completeness of myocardial perfusion (p < 0.005), and average systolic blood pressure (p < 0.05). Mitral systolic tenting area (p < 0.0001) in a statistical model with scarring of the anterior-lateral region (p < 0.05) proved to be the most powerful predictor of MR severity (r2 = 0.31). Mitral annular dilatation in the anterior-posterior direction (p < 0.0001) and diminished LV systolic function (p < 0.005) were important determinants of mitral systolic tenting area (r2 = 0.57).
CONCLUSIONS: Mitral tenting in combination with regional left ventricular myocardial scarring are important mechanisms to the development of ischemic MR. Surgical annuloplasty addresses mitral tenting, but has little impact on the effect of regional scarring. Moderate-to-severe ischemic MR develops in patients with regional scarring of the anterior-lateral and inferior-posterior regions, and new surgical developments should take this into account.
This article has been cited by other articles:
![]() |
T. H Marwick, P. Lancellotti, and L. Pierard Ischaemic mitral regurgitation: mechanisms and diagnosis Heart, October 15, 2009; 95(20): 1711 - 1718. [Full Text] [PDF] |
||||
![]() |
F. Langer, T. Kunihara, K. Hell, R. Schramm, K. I. Schmidt, D. Aicher, M. Kindermann, and H.-J. Schafers RING+STRING: Successful Repair Technique for Ischemic Mitral Regurgitation With Severe Leaflet Tethering Circulation, September 15, 2009; 120(11_suppl_1): S85 - S91. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Onorati, A. S. Rubino, D. Marturano, E. Pasceri, G. Santarpino, S. Zinzi, G. Mascaro, and A. Renzulli Midterm clinical and echocardiographic results and predictors of mitral regurgitation recurrence following restrictive annuloplasty for ischemic cardiomyopathy J. Thorac. Cardiovasc. Surg., September 1, 2009; 138(3): 654 - 662. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sack, P. Kahlert, L. Bilodeau, L. A. Pierard, P. Lancellotti, V. Legrand, J. Bartunek, M. Vanderheyden, R. Hoffmann, P. Schauerte, et al. Percutaneous Transvenous Mitral Annuloplasty: Initial Human Experience With a Novel Coronary Sinus Implant Device Circ Cardiovasc Interv, August 1, 2009; 2(4): 277 - 284. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D'Ancona, D. Biondo, G. Mamone, G. Marrone, F. Pirone, G. Santise, S. Sciacca, and M. Pilato Ischemic mitral valve regurgitation in patients with depressed ventricular function: cardiac geometrical and myocardial perfusion evaluation with magnetic resonance imaging Eur. J. Cardiothorac. Surg., November 1, 2008; 34(5): 964 - 968. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-u Fumimoto, T. Fukui, T. Shimokawa, and S. Takanashi Papillary muscle realignment and mitral annuloplasty in patients with severe ischemic mitral regurgitation and dilated heart Interactive CardioVascular and Thoracic Surgery, June 1, 2008; 7(3): 368 - 371. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. H. Marwick Restrictive Annuloplasty for Ischemic Mitral Regurgitation: Too Little or Too Much? J. Am. Coll. Cardiol., April 29, 2008; 51(17): 1702 - 1703. [Full Text] [PDF] |
||||
![]() |
E. Agricola, M. Oppizzi, M. Pisani, A. Meris, F. Maisano, and A. Margonato Ischemic mitral regurgitation: mechanisms and echocardiographic classification Eur J Echocardiogr, March 1, 2008; 9(2): 207 - 221. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. I. Fann, N. B. Ingels Jr., and D. C. Miller Pathophysiology of Mitral Valve Disease Card. Surg. Adult, January 1, 2008; 3(2008): 973 - 1012. [Full Text] |
||||
![]() |
L. P. Ryan, B. M. Jackson, L. M. Parish, H. Sakamoto, T. J. Plappert, M. St. John-Sutton, J. H. Gorman III, and R. C. Gorman Mitral Valve Tenting Index for Assessment of Subvalvular Remodeling Ann. Thorac. Surg., October 1, 2007; 84(4): 1243 - 1249. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D'Ancona, G. Mamone, G. Marrone, F. Pirone, G. Santise, S. Sciacca, and M. Pilato Ischemic mitral valve regurgitation: the new challenge for magnetic resonance imaging Eur. J. Cardiothorac. Surg., September 1, 2007; 32(3): 475 - 480. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Ryan, B. Jackson, L. Parish, H. Sakamoto, T. Plappert, M. St. J. Sutton, J. Gorman III, and R. Gorman Quantification and localization of mitral valve tenting in ischemic mitral regurgitation using real-time three-dimensional echocardiography Eur. J. Cardiothorac. Surg., May 1, 2007; 31(5): 839 - 844. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Zanettini, A. Antonini, G. Gatto, R. Gentile, S. Tesei, and G. Pezzoli Valvular Heart Disease and the Use of Dopamine Agonists for Parkinson's Disease N. Engl. J. Med., January 4, 2007; 356(1): 39 - 46. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Sartipy, A. Albage, and D. Lindblom Risk factors for mortality and hospital re-admission after surgical ventricular restoration Eur. J. Cardiothorac. Surg., November 1, 2006; 30(5): 762 - 769. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |